๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma
NCT06961669Lymphoblastic Leukemia, Relapsed or Refractory Multiple Myeloma (RRMM)
Anhui Provincial Hospital
Not applicable
18
Hefei
2025-04-16
Recruiting
A Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer
NCT07101679Locally Advanced Pancreatic Ductal Adenocarcinoma
West China Hospital
Phase 2
23
Chengdu
2025-04-16
Recruiting
Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)
NCT07601763Atrial Fibrillation (AF), Atrial Fibrillation Ablation, Atrial Fibrillation Recurrent, Pulsed Field Ablation
China National Center for Cardiovascular Diseases
Not applicable
1,574
Beijing
2025-04-16
Recruiting
SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC
NCT06927180Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Henan Cancer Hospital
Phase 2
180
Zhengzhou
2025-04-16
Recruiting
A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer Patients
NCT06832202HER2-low Hormone Receptor Positive Breast Cancer
Shanghai Henlius Biotech
Phase 2
50
Shanghai
2025-04-16
By invitation
Pseudomonas Aeruginosa Injection Combined With Polyvinylpyrrolidone-Iodine in Immediate Breast Reconstruction Surgery With Implants
NCT07460297Postoperative Seroma Rate, Drainage Tube Removal Time, and Capsular Contracture Rate, Seroma Following Procedure
Jianyi Li
Not applicable
100
Shenyang
2025-04-16
Recruiting
Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome
NCT06842524Polycystic Ovary Syndrome (PCOS)
Shanghai Zhongshan Hospital
Phase 2
150
Xiamen, Shanghai, Wenzhou
2025-04-16
Recruiting
Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease
NCT07324161Alzheimer s Disease
Fujian Medical University Union Hospital
Not applicable
81
Fuzhou
2025-04-16
Recruiting
A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus
NCT06943937Lupus Nephritis (LN), Immune Thrombocytopenia (ITP)
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
36
Beijing
2025-04-16
Recruiting
The Efficacy and Safety of Venostan in Promoting Postoperative Swelling Reduction in Patients With Ankle Fractures
NCT06872034Swelling/ Edema
Beijing Jishuitan Hospital
Not applicable
290
Beijing
2025-04-16
Recruiting
A Study of HS-20094 in Overweight or Obese Participants
NCT07057674Overweight or Obesity
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
144
Qingdao
2025-04-16
Not yet open
Shenfu Injection Modulates Carotid Elasticity in Septic Shock
NCT06915506Septic Shock, Vascular Dysfunction, Arterial Stiffness, Carotid Artery Elasticity Alterations
First Affiliated Hospital of Wannan Medical College
Phase 4
48
Wuhu
2025-04-15
Not yet open
(Withdrawal) AI-Based Low-Dose 3D-DSA Reconstruction
NCT06769867Cerebrovascular Disease
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
134
Wuhan
2025-04-15
Active, closed
Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older
NCT06904222Respiratory Syncytial Virus Infection
Guangzhou Patronus Biotech Co., Ltd.
Phase 1
90
Dangyang
2025-04-15
Not yet open
Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
NCT06916975Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic
Jin Xu
Phase 2
46
Shanghai
2025-04-15
Recruiting
A Study of HS-20122 in Patients With Advanced Solid Tumors
NCT06927570Advanced Solid Tumors
Hansoh BioMedical R&D Company
Phase 1
1,050
Guangzhou
2025-04-15
Recruiting
Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer
NCT06860529HR+/HER2- Breast Cancer
Henan Cancer Hospital
Phase 2
357
Zhengzhou
2025-04-15
Recruiting
Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.
NCT06772064SIBO
Xiuli Zuo
Not applicable
115
Jinan
2025-04-15
Recruiting
Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging
NCT06817733Benign Prostatic Hyperplasia (BPH)
Chinese PLA General Hospital
Not applicable
30
Beijing
2025-04-15
Not yet open
A Randomized Trial of the Rapamycin Target Eluting Stent for the Treatment of Symptomatic Cerebral Artery Atherosclerotic Disease๏ผˆTARGET-DREAM๏ผ‰
NCT06925971Intracranial Arteriosclerosis
MicroPort NeuroTech Co., Ltd.
Phase 3
279
Shanghai
2025-04-15
Recruiting
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC
NCT07647289Muscle-Invasive Bladder Cancer (MIBC)
Peking University Third Hospital
Phase 2
58
Beijing
2025-04-15
Active, closed
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
NCT06900543Unresectable Hepatocellular Carcinoma
Chengdu New Radiomedicine Technology Co. LTD.
Phase 3
108
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Nanjing, Shenyang, Xiโ€™an, Chengdu
2025-04-15
Recruiting
Electrical Impedance Tomography-Based Prognostic Model for ARDS
NCT06967207Acute Respiratory Distress Syndrome (ARDS), Ventilator-induced Lung Injury
XiaoJing Zou,MD
Observational
625
Guangzhou, Wuhan, Shanghai
2025-04-15
Recruiting
Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian Syndrome
NCT07746635PCOS (Polycystic Ovary Syndrome)
Shanghai Changzheng Hospital
Not applicable
161
Shanghai
2025-04-15
Recruiting
Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO
NCT07152392Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital
Phase 4
50
Shanghai
2025-04-15
Not yet open
9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors
NCT06926998Gynecological Malignancies
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2
260
Hangzhou
2025-04-15
Recruiting
Evaluation of Clinical Effect of Acupuncture on Acute Exacerbation of Bronchial Asthma
NCT07632352Bronchial Asthma
Henan University of Traditional Chinese Medicine
Not applicable
72
Zhengzhou
2025-04-15
Not yet open
Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
NCT06931145Extensive-stage Small Cell Lung Cancer
Peking Union Medical College Hospital
Phase 4
50
Beijing
2025-04-15
Recruiting
A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
NCT06717113Multiple Myeloma and Malignant Plasma Cell Neoplasms
Peking University First Hospital
Phase EARLY_PHASE1
50
Beijing
2025-04-15
Not yet open
ACT-based EMI in College Students
NCT06843395Healthy Participants Study
The Hong Kong Polytechnic University
Not applicable
60
Hong Kong
2025-04-15
Active, closed
Phase Ib Clinical Study to Evaluate the Safety and Tolerability of VSA012 Injection in Paroxysmal Nocturnal Hemoglobinuria
NCT06848296Paroxysmal Nocturnal Hemoglobinuria (PNH)
Bisirna Therapeutics Pte. Ltd.
Phase 1
50
Beijing, Hangzhou
2025-04-15
Active, closed
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
NCT06960889Esophageal Cancer (EsC)
Nanfang Hospital, Southern Medical University
Observational
500
Guangzhou
2025-04-15
Recruiting
Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06925243Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]), Neoadjuvant Therapy, Adjuvant Chemotherapy, pCR Rate
Zuoyi Jiao
Phase 3
682
Lanzhou
2025-04-15
Recruiting
Steroids-Based Screening for Primary Aldosteronism
NCT06941116Primary Aldosteronism, Hypertension
Qifu Li
Observational
406
Chongqing
2025-04-15
Recruiting
Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases
NCT07092202Leptomeningeal Metastasis, NSCLC, Intrathecal Chemotherapy, Tyrosine Kinase Inhibitor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4
40
Wuhan
2025-04-15
Recruiting
FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion
NCT07020858Chronic Total Occlusion (CTO), Chronic Coronary Syndrome
Lin Zhao
Observational
470
Beijing
2025-04-15
Recruiting
Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma
NCT06827717Ewing Sarcoma
Sun Yat-sen University
Phase 2
29
Guangzhou
2025-04-15
Active, closed
Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06914687Gastric Adenocarcinoma, Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma, Peritoneal Metastasis
Fudan University
Phase 2
30
Shanghai
2025-04-15
Recruiting
Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors
NCT06941766Intermediate Trophoblastic Tumor
Peking Union Medical College Hospital
Phase 1/2
20
Beijing
2025-04-15
Recruiting
MCG for Non-Obstructive Myocardial Ischemia
NCT07657546Myocardial Ischemia
Qilu Hospital of Shandong University
Observational
3,786
Jinan
2025-04-15
Recruiting
Hybrid Closed-Loop System in Neurosurgical Perioperative Hyperglycemia: An Open RCT
NCT06909071T2DM Patients With Traumatic Brain Injury
Shanxi Bethune Hospital
Not applicable
40
Taiyuan
2025-04-15
Recruiting
Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.
NCT07152366Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital
Phase 4
96
Shanghai
2025-04-15
Not yet open
Assessing Coronary Non-Culprit Plaque Early with Start of PCSK9 Inhibitors in Acute Myocardial Infarction (ACCESS-AMI)
NCT06854523Acute Myocardial Infarction
Yun Dai Chen
Not applicable
300
Beijing
2025-04-15
Recruiting
Clinical Study on the Healing of Distal Radius Fractures With Conservative Treatment Assisted by Fu's Subcutaneous Needling
NCT07054463Distal Radius Fractures
Guangzhou University of Chinese Medicine
Not applicable
84
Guangzhou
2025-04-15
Recruiting
Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial
NCT06919380Anti-MDA5 Positive Dermatomyositis-Associated RP-ILD, Rapidly Progressive Interstitial Lung Disease
Li Shiyue
Phase 1
10
Guangzhou
2025-04-15
Recruiting
Clinical Intelligent Management System - Multilingual Exploration
NCT06923410Primary Care Diseases
Tsinghua University
Not applicable
40
Beijing
2025-04-15
Recruiting
Study on the Use of Lateral Decubitus Position in Left Breast Cancer Patients Undergoing Adjuvant Radiotherapy
NCT06902051Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Nanfang Hospital, Southern Medical University
Not applicable
86
Guangzhou
2025-04-14
Recruiting
Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)
NCT061604925-aminolevulinic Acid, Fluorescence-guided Resection
Lee's Pharmaceutical Limited
Phase 3
144
Guangzhou, Zhengzhou
2025-04-14
Recruiting
Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell Lymphoma
NCT06846489Mantle Cell Lymphoma (MCL)
Sun Yat-sen University
Phase 2
50
Guangzhou
2025-04-14
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
NCT06858813Hepatocellular Cancer, Squamous-Cell Non-Small Cell Lung Cancer
AbbVie
Phase 1
232
Guangzhou, Shanghai
2025-04-14
Active, closed
Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin
NCT07362030Obesity
Guangdong Raynovent Biotech Co., Ltd
Phase 1
32
Dongguan
2025-04-14
Recruiting
Development and Validation of a Digital Twin-based Clinical Research System (X Town Stage I)
NCT06861283Chronic Disease
Shanghai 6th People's Hospital
Observational
1,500
Wuxi
2025-04-13
Recruiting
Clinical Intelligent Management System Pragmatic RCT
NCT06893068Primary Care Diseases
Tsinghua University
Not applicable
204
Wuxi
2025-04-13
Recruiting
Evaluation of the Efficacy of Electroacupuncture in the Treatment of Functional Dyspepsia
NCT06618911Functional Dyspepsia
Yi Liang
Not applicable
180
Hangzhou
2025-04-13
Recruiting
Natural Course and Therapeutic Effect of Chronic Pancreatitis
NCT06925204Chronic Pancreatitis
Changhai Hospital
Observational
5,000
Shanghai
2025-04-13
Recruiting
Remote Ischemic Conditioning for Acute Moderate Posterior Ischemic Stroke
NCT06931535Ischemic Stroke
General Hospital of Shenyang Military Region
Not applicable
1,600
Shenyang
2025-04-13
Recruiting
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections
NCT07089186Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP), Complicated Intra-abdominal Infection (cIAI), Complicated Urinary Tract Infection (cUTI)
Qilu Pharmaceutical Co., Ltd.
Phase 3
80
Shanghai
2025-04-12
Recruiting
Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Ischemic Stroke
NCT06863571Ischemic Stroke
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
68
Hangzhou
2025-04-12
Recruiting
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
NCT06916624Renal Cell Carcinoma (RCC), Clear Cell Renal Cell Carcinoma (ccRCC)
The Affiliated Hospital of Qingdao University
Observational
120
Qingdao
2025-04-12
Active, closed
Interventional Ablation for Early-stage Lung Cancer
NCT07005999Lung Cancer (NSCLC), Early Stage Lung Non-Small Cell Carcinoma
Guangzhou Institute of Respiratory Disease
Observational
656
Guangzhou
2025-04-12
Recruiting
IVIG Trial for the Treatment of Bronchopulmonary Dysplasia
NCT06925360Bronchopulmonary Dysplasia
International Peace Maternity and Child Health Hospital
Phase 2
20
Shanghai
2025-04-12
Recruiting
18F FDG and 68Ga FAPI PET/MR Imaging of Carotid Artery Plaque Vulnerability: A Clinical Study in Carotid Artery Plaque Patients
NCT07004673Carotid Artery Plaque, Ischemic Stroke, PET / MR
Ruijin Hospital
Observational
100
Shanghai
2025-04-12
Recruiting
Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease
NCT07187167Rosai-Dorfman Disease
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
40
Beijing
2025-04-12
Recruiting
Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH
NCT07187193Langerhans Cell Histiocytosis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
50
Beijing
2025-04-12
Recruiting
Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion
NCT06968572Advanced Solid Tumors
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
245
Guiyang, Nanjing, Shanghai
2025-04-11
Recruiting
COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patients: A Multicenter, Randomized, Controlled Clinical Trial
NCT06796764Hypoxia, Esophageal Cancer, Gastric Cancer
Zhejiang University
Not applicable
580
Hangzhou
2025-04-11
Recruiting
First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors
NCT06877650Advanced Malignant Tumors
Shanghai JMT-Bio Inc.
Phase 1/2
436
Shanghai
2025-04-11
Active, closed
A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males
NCT06866574Penile/Perineal /Perianal Intraepithelial Neoplasia, Anal Intraepithelial Neoplasia, Penile/Perianal/Perineal Cancer, Anal Cancer
Xiamen University
Phase 3
9,300
Fuzhou, Chengdu, Kunming, Hangzhou
2025-04-11
Recruiting
UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
NCT06743503Large B-cell Lymphoma
Nanjing IASO Biotechnology Co., Ltd.
Phase 1
70
Nanjing, Tianjin
2025-04-11
Recruiting
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ยฑ Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
NCT06821503Advanced Pancreatic Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
72
Beijing, Chongqing, Harbin, Zhengzhou, Wuhan, Nanjing, Nanchang, Shenyang
2025-04-11
Recruiting
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour
NCT06888830Advanced Malignant Solid Tumours
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2
374
Shanghai
2025-04-11
Recruiting
A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard Treatment
NCT06987500Tumor, Solid
Evopoint Biosciences Inc.
Phase 1/2
132
Beijing
2025-04-11
Recruiting
Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer
NCT06916338Breast Cancer
The Affiliated Hospital of Qingdao University
Observational
30
Qingdao
2025-04-11
Recruiting
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function
NCT07141030Obesity/Overweight
Gan & Lee Pharmaceuticals.
Phase 1
32
Beijing
2025-04-11
Recruiting
A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder
NCT06958692Major Depressive Disorder (MDD)
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 3
388
Beijing
2025-04-11
Recruiting
The Treatment of Moderate to Severe Allergic Rhinitis With Electroacupuncture Combined With Microneedle Knife
NCT06890260Allergic Rhinitis (Disorder), Electroacupuncture, Microneedle Knife
Pengfei Qiu
Not applicable
90
Hangzhou
2025-04-11
Recruiting
Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (โ… ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study
NCT06888050New-onset Type 2 Diabetes
Zhejiang Provincial People's Hospital
Phase 4
268
Hangzhou
2025-04-11
Recruiting
Effect of Ciprofol on Intraoperative Hypotension in Elderly Patients Receiving Renin-angiotensin System Inhibitors
NCT06952608Intraoperative Hypotension, Ciprofol, Renin-angiotensin System Inhibitors
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
140
Hangzhou
2025-04-10
Recruiting
Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy
NCT06992336Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
411
Guangzhou
2025-04-10
Recruiting
Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children
NCT07188311Hepatoblastoma, Pediatric Cancer
Sun Yat-sen University
Not applicable
24
Guangdong
2025-04-10
Recruiting
Randomized Controlled Trial on the Efficacy and Safety of Xiang Lei Ointment in Diabetic-related Ulcer Management
NCT06841237Diabetic Wound, Wound Infection, Wound Heal
Peking University Third Hospital
Not applicable
56
Beijing
2025-04-10
Not yet open
A Prediction Model of Prolonged Mechanical Ventilation Following Acute Type A Aortic Dissection Surgery
NCT06929780Acute Type A Aortic Dissection
China-Japan Friendship Hospital
Observational
1,400
Beijing
2025-04-10
Recruiting
A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
NCT06800196Solid Tumors With FGFR2 Alterations, Adult
KinoTeck Therapeutics Co., Ltd
Phase 1
151
Guangzhou
2025-04-10
Recruiting
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
NCT07022197Chronic Inflammatory Demyelinating Polyradiculoneuropathy, NMO Spectrum Disorder, Myasthenia Gravis, Idiopathic Inflammatory Myopathies
Tianjin Medical University General Hospital
Phase 1/2
27
Tianjin
2025-04-10
Recruiting
Universal CAR-T Cell Therapy for MM
NCT07248176Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Bioray Laboratories
Not applicable
6
Shanghai
2025-04-10
Active, closed
Photobiomodulation Therapy vs. Alpha-Lipoic Acid in Burning Mouth Syndrome Treatment
NCT07381361Burning Mouth Syndrome, Low Level Laser Therapy
Lu Jiang
Not applicable
60
Chengdu
2025-04-10
Recruiting
SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
NCT06794086Colorectal Cancer, Liver Metastases
Jun Huang
Phase 3
24
Guangzhou
2025-04-10
Recruiting
The Effects of Cosmetic Acupuncture
NCT06952959Aging, Skin Health
China Medical University Hospital
Not applicable
40
2025-04-10
Recruiting
Efficacy of Lactobacillus Rhamnosus LRa05 in Gestational Diabetes
NCT06901791GDM
Wecare Probiotics Co., Ltd.
Not applicable
80
Suzhou
2025-04-10
Recruiting
Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
NCT06947707Cerebral Venous Thrombosis, Anticoagulants and Thrombotic Disorders, Anticoagulation Treatment, Anticoagulant Therapy
Xuanwu Hospital, Beijing
Observational
1,486
Beijing
2025-04-10
Recruiting
The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.
NCT06930118Advanced Colorectal Cancer in the Third-line Treatment and Beyond, pMMR/MSS Advanced Colorectal Cancer
Shanghai Changzheng Hospital
Phase 2
60
Shanghai
2025-04-10
Recruiting
Silkworm Pupa Powder Improves Dementia.
NCT06898476Alzheimer Disease(AD), Sarcopenia, Asthenia
Zhejiang Provincial Tongde Hospital
Not applicable
300
Hangzhou
2025-04-10
Not yet open
Efficacy of Remote Ischemic Conditioning in Preventing Post-Stroke Depression
NCT06920706Post-stroke Depression, Remote Ischemic Conditioning
Xuanwu Hospital, Beijing
Not applicable
240
Tongren, Baoding, Jilin City, Jincheng, Beijing
2025-04-10
Recruiting
Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer
NCT07066280Skin Microbiome, Breast Cancer, Radiation Dermatitis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
326
Guangzhou
2025-04-10
Recruiting
Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity
NCT06820099Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity
Shandong Suncadia Medicine Co., Ltd.
Phase 2
225
Beijing
2025-04-10
Recruiting
TCM Daoyin for Anxiety/Depression: Psychological Effects and Biological Mechanisms
NCT06921512Anxiety Symptom, Depression Symptom
Shanghai University of Traditional Chinese Medicine
Not applicable
20
Shanghai
2025-04-10
Recruiting
The Effectiveness of Group Guided Written Exposure Therapy for CPTSD Symptoms Among Adolescents
NCT06931093CPTSD, Compelx Post-traumatic Stress Disorder
Peking University
Not applicable
120
Beijing
2025-04-10
Recruiting
A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
NCT06776952Relapsed/Refractory Peripheral T Cell Lymphoma
Evopoint Biosciences Inc.
Phase 3
120
Beijing
2025-04-10
Recruiting
A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors
NCT06970795Small Cell Lung Cancer, Other Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1
180
Changchuan
2025-04-10
Recruiting
The Electroencephalographic Mechanisms of Anesthesia and Human Consciousness
NCT07145697Consciousness, Level Altered
Guangzhou General Hospital of Guangzhou Military Command
Phase 4
30
Guangzhou
2025-04-10
Rows per page Showing 8501–8600 of 19052
Previous 84 85 86 87 88 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=86

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.